hotspot -WSS

hotspot

author：entertainment 2025-10-02 22:58:21 - browse：9852

Illustration of a red heart. -- health coverage from STAT — Adobe

Novo Nordisk’s obesity drug Wegovy cut the risk of major heart complications by 20% in a closely watched trial, results that could streamline insurance coverage and spur even greater demand for the highly popular therapy.

The milestone Select trial of about 17,500 patients is the first to show that an obesity medication leads to long-term cardiovascular benefits. The company reported only the topline figure in a press release Tuesday, and did not break out the reductions it said were seen in heart attacks, strokes, and cardiovascular deaths — the combined components of the study’s primary outcome. It said all three contributed to the decrease in cardiovascular events in the group that received Wegovy compared with participants given a placebo.

The 20% reduction was greater than many observers were expecting. In a research note Tuesday, Jefferies analysts called the results a “best case” outcome. “If they play baseball in Denmark,” Barclays analyst Emily Field wrote in a note, “Wegovy just hit a home run.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： U.K. researchers warn about biases in medical devices, algorithms

WSS

Experts study whether long Covid risk adds up with each reinfection

Lawsuit highlights wrinkle for disputes over surprise medical bills

The biotech scorecard for Q4: 16 stock

Study points to new risk in gene therapy death of Terry Horgan

IVG is promising — but it won’t replace IVF quite yet

Setback for rare diseases as Taysha Gene Therapies pulls back

focus

hotspot

entertainment

Medicare details structure of new drug price negotiation program

Orchard's therapy for neuron disease in children wins FDA approval

Psychedelics group wrestles with new pharma identity

Nurses recount patients attacks

23andMe had bad news about my health. I wish a person had delivered it

Nobel honors Karikó and Weissman's enduring partnership

Dobbs anniversary: the lost opportunity of abortion as health care

Nurses recount patients attacks

How to save PrEP access — and even expand it

Future doctors should be trained to promote social change

knowledge

Stop Congress from blocking public access to science

CDC picks Alphabet's Verily for wasterwater surveillance contract

Health insurers' Q3 question: how much care are people getting?

Colonoscopy prep: Liquid

Future doctors should be trained to promote social change

Colonoscopy prep: Liquid

explore

knowledge

explore

hotspot